BSE Live
Oct 17, 16:01Prev. Close
358.10
Open Price
360.05
Bid Price (Qty.)
354.70 (200)
Offer Price (Qty.)
357.00 (9)
NSE Live
Oct 17, 15:59Prev. Close
358.20
Open Price
360.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
356.15 (919)
Key Financial Ratios of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 3.72 | 8.33 | 4.04 | 26.45 | 18.78 | |
Diluted EPS (Rs.) | 3.71 | 8.27 | 4.02 | 26.27 | 18.76 | |
Cash EPS (Rs.) | 4.49 | 10.66 | 6.24 | 33.50 | 25.42 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 62.80 | 118.58 | 112.30 | 327.01 | 299.79 | |
Book Value [InclRevalReserve]/Share (Rs.) | 62.81 | 118.59 | 112.31 | 327.06 | 299.83 | |
Dividend / Share(Rs.) | 0.50 | 0.50 | 1.00 | 1.00 | 5.00 | |
Revenue from Operations/Share (Rs.) | 16.57 | 48.08 | 40.32 | 129.40 | 115.09 | |
PBDIT/Share (Rs.) | 4.06 | 8.39 | 7.38 | 34.53 | 29.51 | |
PBIT/Share (Rs.) | 3.25 | 5.93 | 5.11 | 27.00 | 22.52 | |
PBT/Share (Rs.) | 4.57 | 9.20 | 5.10 | 26.81 | 27.97 | |
Net Profit/Share (Rs.) | 3.67 | 8.21 | 3.98 | 25.97 | 18.43 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 24.52 | 17.44 | 18.30 | 26.68 | 25.63 | |
PBIT Margin (%) | 19.59 | 12.34 | 12.68 | 20.86 | 19.56 | |
PBT Margin (%) | 27.56 | 19.13 | 12.64 | 20.71 | 24.30 | |
Net Profit Margin (%) | 22.17 | 17.07 | 9.85 | 20.06 | 16.01 | |
Return on Networth / Equity (%) | 5.85 | 6.92 | 3.53 | 7.94 | 6.14 | |
Return on Capital Employed (%) | 5.13 | 4.91 | 3.45 | 7.67 | 5.91 | |
Return on Assets (%) | 5.30 | 5.97 | 3.08 | 6.95 | 5.19 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.01 | 0.02 | 0.06 | |
Asset Turnover Ratio (%) | 23.92 | 35.00 | 31.30 | 34.64 | 32.42 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.86 | 2.46 | 2.47 | 3.37 | 2.75 | |
Quick Ratio (X) | 2.13 | 1.66 | 1.80 | 2.61 | 2.16 | |
Inventory Turnover Ratio (X) | 3.72 | 3.60 | 4.31 | 4.80 | 4.56 | |
Dividend Payout Ratio (NP) (%) | 13.63 | 14.08 | 29.05 | 0.00 | 30.03 | |
Dividend Payout Ratio (CP) (%) | 11.15 | 10.84 | 18.49 | 0.00 | 21.77 | |
Earnings Retention Ratio (%) | 86.37 | 85.92 | 70.95 | 0.00 | 69.97 | |
Cash Earnings Retention Ratio (%) | 88.85 | 89.16 | 81.51 | 0.00 | 78.23 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 32,097.40 | 36,305.40 | 35,522.30 | 22,419.50 | 9,361.00 | |
EV/Net Operating Revenue (X) | 16.14 | 12.59 | 14.68 | 8.66 | 4.07 | |
EV/EBITDA (X) | 65.81 | 72.16 | 80.20 | 32.46 | 15.86 | |
MarketCap/Net Operating Revenue (X) | 16.33 | 12.71 | 14.74 | 8.76 | 4.19 | |
Retention Ratios (%) | 86.36 | 85.91 | 70.94 | 0.00 | 69.96 | |
Price/BV (X) | 4.31 | 5.15 | 5.29 | 3.47 | 1.61 | |
Price/Net Operating Revenue | 16.33 | 12.71 | 14.74 | 8.76 | 4.19 | |
Earnings Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
17.10.2025
18.09.2025
18.09.2025
11.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y